相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma
Jun Han et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
Zhenyu Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy
Po-Li Wei et al.
PLOS ONE (2019)
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma
Libin Yan et al.
THERANOSTICS (2019)
SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance
Tao Wang et al.
CANCER LETTERS (2018)
Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation
Tetsuyuki Takahashi et al.
HEPATOLOGY INTERNATIONAL (2018)
Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor
Seong-Hoon Yun et al.
PPAR RESEARCH (2018)
Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
Shan-Ru Zuo et al.
JOURNAL OF CANCER (2018)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
SMYD5 regulates H4K20me3-marked heterochromatin to safeguard ES cell self-renewal and prevent spurious differentiation
Benjamin L. Kidder et al.
EPIGENETICS & CHROMATIN (2017)
The prognostic impacts of TEA domain (TEAD) transcription factor polymorphisms in chinese hepatocellular carcinoma patients
Haiyan Xia et al.
ONCOTARGET (2017)
Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray
Hai Hu et al.
ONCOTARGET (2017)
SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation
Benjamin L. Kidder et al.
CANCER RESEARCH (2017)
Automated multigroup outlier identification in molecular high-throughput data using bagplots and gemplots
Jochen Kruppa et al.
BMC BIOINFORMATICS (2017)
Comparison of hepatocellular carcinoma in Eastern versus Western populations
Su Pin Choo et al.
CANCER (2016)
Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development
Michalis E. Sarris et al.
CANCER CELL (2016)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
Smyd5 plays pivotal roles in both primitive and definitive hematopoiesis during zebrafish embryogenesis
Tomoaki Fujii et al.
SCIENTIFIC REPORTS (2016)
Structure and Function of SET and MYND Domain-Containing Proteins
Nicholas Spellmon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species
Eduardo Calpena et al.
PLOS ONE (2015)
SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
Filipa Quintela Vieira et al.
ONCOTARGET (2015)
Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
Aritro Nath et al.
SCIENTIFIC REPORTS (2015)
SMYD Proteins: Key Regulators in Skeletal and Cardiac Muscle Development and Function
Shao Jun Du et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2014)
New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma
Antoine Galmiche et al.
CANCER LETTERS (2014)
SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor
Luis Henrique Toshihiro Sakamoto et al.
LEUKEMIA RESEARCH (2014)
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer
Pawel K. Mazur et al.
NATURE (2014)
HCC therapies-lessons learned
Marcus-Alexander Woerns et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
Li-Li Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Cellular Fatty Acid Metabolism and Cancer
Erin Currie et al.
CELL METABOLISM (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Control of Proinflammatory Gene Programs by Regulated Trimethylation and Demethylation of Histone H4K20
Joshua D. Stender et al.
MOLECULAR CELL (2012)
Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation
Zhenfei Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2
Mohamed Abu-Farha et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
SET/MYND Lysine Methyltransferases Regulate Gene Transcription and Protein Activity
Kristin Leinhart et al.
GENES (2011)
Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo
Cheng Jin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression
Wen Liu et al.
NATURE (2010)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cytochrome P450 pharmacogenetics and cancer
C Rodriguez-Antona et al.
ONCOGENE (2006)
SmyD1, a histone methyltransferase, is required for myofibril organization and muscle contraction in zebrafish embryos
XG Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance - Focus on tamoxifen, paclitaxel and imatinib metabolism
B Rochat
CLINICAL PHARMACOKINETICS (2005)
分享论文
